These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33722396)

  • 1. Adherence to Chronic Kidney Disease Screening Guidelines Among Patients With Type 2 Diabetes in a US Administrative Claims Database.
    Folkerts K; Petruski-Ivleva N; Comerford E; Blankenburg M; Evers T; Gay A; Fried L; Kovesdy CP
    Mayo Clin Proc; 2021 Apr; 96(4):975-986. PubMed ID: 33722396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study.
    Folkerts K; Kelly AMB; Petruski-Ivleva N; Fried L; Blankenburg M; Gay A; Velentgas P; Kovesdy CP
    Nephron; 2021; 145(4):342-352. PubMed ID: 33789294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographical variation in kidney function testing and associations with health care costs among patients with chronic kidney disease and type 2 diabetes.
    Betts KA; Song J; Elliott J; Warnock N; Farej R; Wu A; Singh R
    Am J Manag Care; 2022 Aug; 28(6 Suppl):S112-S119. PubMed ID: 35997775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
    Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M
    BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
    Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
    Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing.
    Christofides EA; Desai N
    J Prim Care Community Health; 2021; 12():21501327211003683. PubMed ID: 33749371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Population-Based Analysis of Quality Indicators in CKD.
    Manns L; Scott-Douglas N; Tonelli M; Weaver R; Tam-Tham H; Chong C; Hemmelgarn B
    Clin J Am Soc Nephrol; 2017 May; 12(5):727-733. PubMed ID: 28377473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study.
    Fraser SD; Parkes J; Culliford D; Santer M; Roderick PJ
    BMC Fam Pract; 2015 Feb; 16():18. PubMed ID: 25879207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations.
    Stempniewicz N; Vassalotti JA; Cuddeback JK; Ciemins E; Storfer-Isser A; Sang Y; Matsushita K; Ballew SH; Chang AR; Levey AS; Bailey RA; Fishman J; Coresh J
    Diabetes Care; 2021 Sep; 44(9):2000-2009. PubMed ID: 34233925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes.
    Sheer R; Nair R; Pasquale MK; Evers T; Cockrell M; Gay A; Singh R; Schmedt N
    J Prim Care Community Health; 2022; 13():21501319211063726. PubMed ID: 35068244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Bariatric Surgery on Diagnosed Chronic Kidney Disease and Cardiovascular Events in Patients with Insulin-treated Type 2 Diabetes: a Retrospective Cohort Study from a Large UK Primary Care Database.
    Alkharaiji M; Anyanwagu U; Donnelly R; Idris I
    Obes Surg; 2020 May; 30(5):1685-1695. PubMed ID: 32130651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
    Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
    Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for microalbuminuria in patients with type 2 diabetes is incomplete in general practice.
    Knudsen ST; Mosbech TH; Hansen B; Kønig E; Johnsen PC; Kamper AL
    Dan Med J; 2012 Sep; 59(9):A4502. PubMed ID: 22951198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study.
    Kovesdy CP; Isaman D; Petruski-Ivleva N; Fried L; Blankenburg M; Gay A; Velentgas P; Folkerts K
    Clin Kidney J; 2021 Jun; 14(6):1657-1664. PubMed ID: 34084461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility.
    James G; Garcia Sanchez JJ; Carrero JJ; Kumar S; Pecoits-Filho R; Heerspink HJL; Nolan S; Lam CSP; Chen H; Kanda E; Kashihara N; Arnold M; Kosiborod MN; Lainscak M; Pollock C; Wheeler DC
    Kidney Int Rep; 2022 Sep; 7(9):2059-2070. PubMed ID: 36090504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function.
    Okubo A; Nakashima A; Doi S; Doi T; Ueno T; Maeda K; Tamura R; Yamane K; Masaki T
    Clin Exp Nephrol; 2020 May; 24(5):435-443. PubMed ID: 32076888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological Variability of Estimated GFR and Albuminuria in CKD.
    Waikar SS; Rebholz CM; Zheng Z; Hurwitz S; Hsu CY; Feldman HI; Xie D; Liu KD; Mifflin TE; Eckfeldt JH; Kimmel PL; Vasan RS; Bonventre JV; Inker LA; Coresh J;
    Am J Kidney Dis; 2018 Oct; 72(4):538-546. PubMed ID: 30031564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.